Monogram Technologies Inc. (MGRM)
| Market Cap | 63.40M |
| Revenue (ttm) | 364,999 |
| Net Income (ttm) | -15.73M |
| Shares Out | 31.70M |
| EPS (ttm) | -0.50 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 100,192 |
| Open | 2.020 |
| Previous Close | 2.040 |
| Day's Range | 1.960 - 2.040 |
| 52-Week Range | 1.530 - 4.900 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 14, 2024 |
About MGRM
Monogram Technologies Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monog... [Read more]
Financial Performance
Financial StatementsNews
Monogram Technologies Inc. (MGRM) Q3 2024 Earnings Call Transcript
Monogram Technologies Inc. (NASDAQ:MGRM) Q3 2024 Earnings Call Transcript November 19, 2024 4:30 PM ET Company Participants Ben Sexson - CEO Noel Knape - CFO Larry Holub - IR Conference Call Particip...
Monogram Technologies Reports Third Quarter 2024 Financial Results
Closed an Upsized and Oversubscribed $13 Million Public Offering to Fund Near-term Commercialization Milestones Management to Host Business Update Conference Call on Tuesday, November 19, 2024 at 4:30...
Monogram Technologies to Host Third Quarter 2024 Results Conference Call on Tuesday, November 19, 2024 at 4:30 p.m. Eastern Time
AUSTIN, TX / ACCESSWIRE / November 12, 2024 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial fo...
Monogram Technologies Named Orthopedic Joint Replacement Company of the Year 2024
Award from Medical Tech Outlook Highlights Monogram's mBôs TKA System AUSTIN, TX / ACCESSWIRE / October 29, 2024 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven ...
Monogram Technologies to Present at the LD Micro Main Event XVII Conference on Wednesday October 30, 2024
AUSTIN, TX / ACCESSWIRE / October 16, 2024 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial foc...
CORRECTION FROM SOURCE: Monogram Technologies Issues Correction to Press Release Announcing it Received an FDA Response for its mBôs TKA System
Company Has 180 Days From Receipt to Produce Additional Information AUSTIN, TX / ACCESSWIRE / October 3, 2024 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven rob...
Monogram Technologies Receives FDA Response for mBôs TKA System
Company to Conduct Clinical Trial to Produce Additional Information Within 180 Days AUSTIN, TX / ACCESSWIRE / October 2, 2024 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), ...
Monogram Technologies Announces Closing of Upsized and Oversubscribed $13 Million Public Offering
AUSTIN, TX / ACCESSWIRE / October 2, 2024 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial focu...
Monogram Technologies Announces Preferred Stock Dividends
AUSTIN, TX / ACCESSWIRE / October 1, 2024 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial focu...
Monogram Technologies Upsizes 8.00% Series D Convertible Cumulative Preferred Stock and Warrant Offering to $12.5 Million
AUSTIN, TX / ACCESSWIRE / September 11, 2024 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial f...
Monogram Technologies Inc. (MGRM) Q2 2024 Earnings Call Transcript
Monogram Technologies Inc. (MGRM) Q2 2024 Earnings Call Transcript
Monogram Technologies Reports Second Quarter 2024 Financial Results
Submitted FDA 510(k) Application and Passed FDA Administrative Review for the mBôs TKA System Secured Initial Strategic Multicenter Clinical Trial Collaboration with Shalby Limited Management to Host ...
Monogram Technologies Secures Initial Strategic Clinical Trial Collaboration
Clinical Trial Collaboration Follows 510(k) Submission and Passing of FDA Administrative Review; Preludes Planned International Launch for the mBȏs TKA System Strategic Partner Shalby is Recognized as...
Monogram Technologies Submits 510(k) Application for mBôs TKA System Clearance
Application was Submitted on July 19, 2024, Passed the FDA Administrative Review, and is Now Under Substantive Review FDA Decision is Expected Within 90 Days of Initial Submission; However, the Proces...
Monogram Technologies to Host Second Quarter 2024 Business Update Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time
AUSTIN, TX / ACCESSWIRE / August 1, 2024 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial focus...
Monogram Technologies to Host Investor and Analyst Tour at its Headquarters in Austin, Texas, on Thursday, June 20th, 2024
Management to Showcase Product Demonstration of mBôs Precision Robotic Surgical System and mVision Technologies AUSTIN, TX / ACCESSWIRE / June 3, 2024 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Mono...
Monogram Technologies Inc. (MGRM) Q1 2024 Earnings Call Transcript
Monogram Technologies Inc. (NASDAQ:MGRM) Q1 2024 Earnings Conference Call May 22, 2024 4:30 PM ET Company Participants Larry Holub - Investor Relations, MZ Group North America Noel Knape - Chief Fina...
Monogram Orthopaedics Completes Corporate Name Change to Monogram Technologies
New Name Reflects Continued Evolution as an AI-Driven Robotics Company with a Strong IP Position AUSTIN, TX / ACCESSWIRE / May 15, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "C...
Monogram Orthopaedics Reports First Quarter 2024 Financial Results
Verification and Validation Testing Expected to be Largely Complete in Q2 2024; 510(k) Submission with FDA Accelerated for Second Half of 2024 Engaged Contract Research Organization to Oversee mBôs Ro...
Monogram Engages Contract Research Organization to Oversee mBôs Robot Clinical Trial Activities Outside the U.S.
CRO Expands Clinical Capabilities, Accelerating Product Pipeline Development and Commercialization Opportunities AUSTIN, TX / ACCESSWIRE / May 13, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Mon...
Monogram Provides Regulatory Update Following Meeting with FDA
510(k) Submission with FDA Accelerated for Early Second Half of 2024 AUSTIN, TX / ACCESSWIRE / May 1, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven roboti...
Monogram Accepted to NVIDIA Inception Program
Collaboration to Provide Monogram with Technical Resources to Drive Development and Commercialization of mBôs System AUSTIN, TX / ACCESSWIRE / April 11, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM)...
Monogram Orthopaedics, Inc. (MGRM) Q4 2023 Earnings Call Transcript
Monogram Orthopaedics, Inc. (MGRM) Q4 2023 Earnings Call Transcript
Monogram Orthopaedics to Host Business Update Conference Call on Thursday, March 21st at 5:00 p.m. Eastern Time
AUSTIN, TX / ACCESSWIRE / March 20, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), a medical technology company focused on reconstructive joint procedures and surgical ...
Monogram Orthopaedics Reports Full Year 2023 Financial Results
510(k) Submission with FDA On Track for Second Half of 2024 Shipped mBôs Surgical Robot System to First International Customer Introduced mVision Technologies, a Novel Approach to Registration and Tra...